INDSWFTLTDNSEInd-Swift Limited· PharmaceuticalsHighNeutral
Announced Fri, 8 Aug · 18:35 IST

Members of the Exchange are hereby informed that the trading in equity shares of Ind-Swift Limited shall be suspended w.e.f. August 14, 2025 (i.e., closing hours of trading on August 13, 2025) on account of the Scheme of Amalgamation.

Nclt Scheme FiledStrategic Transactions
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Limited's equity shares will be suspended from trading on NSE/BSE effective August 14, 2025, with the suspension taking effect from the close of trading on August 13, 2025. The suspension is on account of a Scheme of Amalgamation, indicating the company is in the process of merging with another entity. Trading suspensions of this nature typically occur once key approvals (such as NCLT sanction) are in place and the merger is approaching completion. Shareholders will not be able to trade the stock on the exchange during the suspension period, and existing shareholders are likely entitled to receive shares or consideration of the amalgamated/transferee entity as per the approved swap ratio.

Likely market impact

Shareholders cannot buy or sell Ind-Swift shares on the exchange after August 13, 2025 until further notice. Existing investors will receive shares or cash consideration of the resulting entity as per the merger scheme, making the stock effectively illiquid on the exchange for now.